Foreign portfolio investors have dumped Indian telecom stocks for the eighth consecutive month, pulling out over Rs 32,000 crore in CY26. H...

Anupam Rasayan India Limited has finalised its acquisition of a controlling interest in Bliss GVS Pharma, marking a strategic expansion int...

Stock market Down Today: On Tuesday, the Indian stock market faced a substantial downturn. This sharp decline came after a previous drop ex...

Indian pharma stocks, including Sun Pharma and Aurobindo Pharma, are in focus after the US exempted India and 19 other countries from 100% ...

Electronics manufacturing companies have received substantial incentives under the production-linked incentive scheme and attracted signifi...

Nifty extended its losing streak to seven weeks, falling 0.88% to 23,140.50 as technical momentum remained bearish. The 23,000–23,200 zone ...

Indian equities suffered a sharp selloff, with Sensex plunging 1,248 points and Nifty falling 1.6% as US Treasury yields hit 19-year highs,...

"From 2030 and beyond, we will see strong earnings from pure discovery-led business, which is our central business, our oncology business a...

India’s long-term economic prospects remain strong despite short-term geopolitical, currency and capital-flow challenges. As the country’s ...

India’s drug regulator has warned against the indiscriminate, repeated or prolonged use of painkillers and antibiotics, citing risks includ...

Abakkus Mutual Fund, led by Sunil Singhania, has received SEBI approval to launch its Specialised Investment Fund (SIF) platform under the ...

HDFC Pharma and Healthcare Fund recorded an impressive 25% return in the last year, surpassing its category average across various time fra...

Aragen Life Sciences is increasing investments in complex drug modalities and manufacturing. The company plans to add significant small-mol...

Nifty enters the week in a corrective, range-bound setup, with 23,000–23,100 emerging as crucial support and 23,500 as the first resistance...

India faces a significant trade deficit with China, importing substantially more goods than it exports. Chinese firms offer superior price ...

As new industries emerge, cash-flow-based lending is poised to play a pivotal role in their growth. With traditional collateral often absen...

India's government plans to streamline drug approval processes for domestic use. Applicants can now start studies after intimating the drug...